nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—malignant glioma	0.557	0.685	CbGaD
Triamcinolone—PTGS2—malignant glioma	0.257	0.315	CbGaD
Triamcinolone—CYP3A4—Temozolomide—malignant glioma	0.0576	1	CbGbCtD
Triamcinolone—Monoplegia—Carmustine—malignant glioma	0.00878	0.0908	CcSEcCtD
Triamcinolone—Hyperadrenocorticism—Temozolomide—malignant glioma	0.00848	0.0878	CcSEcCtD
Triamcinolone—Cushing's syndrome—Carmustine—malignant glioma	0.00598	0.0619	CcSEcCtD
Triamcinolone—Meningitis—Carmustine—malignant glioma	0.0035	0.0362	CcSEcCtD
Triamcinolone—Intracranial pressure increased—Carmustine—malignant glioma	0.00325	0.0336	CcSEcCtD
Triamcinolone—Impaired healing—Carmustine—malignant glioma	0.00314	0.0325	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Carmustine—malignant glioma	0.00228	0.0236	CcSEcCtD
Triamcinolone—Embolism—Temozolomide—malignant glioma	0.00204	0.0211	CcSEcCtD
Triamcinolone—Tooth disorder—Temozolomide—malignant glioma	0.00202	0.0209	CcSEcCtD
Triamcinolone—Myopathy—Temozolomide—malignant glioma	0.00187	0.0194	CcSEcCtD
Triamcinolone—Abscess—Carmustine—malignant glioma	0.00172	0.0178	CcSEcCtD
Triamcinolone—Petechiae—Temozolomide—malignant glioma	0.0016	0.0165	CcSEcCtD
Triamcinolone—Candida infection—Carmustine—malignant glioma	0.0013	0.0134	CcSEcCtD
Triamcinolone—Skin exfoliation—Carmustine—malignant glioma	0.0013	0.0134	CcSEcCtD
Triamcinolone—Neuropathy—Carmustine—malignant glioma	0.00127	0.0132	CcSEcCtD
Triamcinolone—Candida infection—Temozolomide—malignant glioma	0.00125	0.013	CcSEcCtD
Triamcinolone—Skin exfoliation—Temozolomide—malignant glioma	0.00125	0.013	CcSEcCtD
Triamcinolone—Neuropathy—Temozolomide—malignant glioma	0.00123	0.0127	CcSEcCtD
Triamcinolone—Thrombophlebitis—Carmustine—malignant glioma	0.00114	0.0118	CcSEcCtD
Triamcinolone—Diabetes mellitus—Carmustine—malignant glioma	0.00113	0.0117	CcSEcCtD
Triamcinolone—Thrombophlebitis—Temozolomide—malignant glioma	0.0011	0.0114	CcSEcCtD
Triamcinolone—Injury—Carmustine—malignant glioma	0.00107	0.0111	CcSEcCtD
Triamcinolone—Vascular purpura—Temozolomide—malignant glioma	0.00106	0.011	CcSEcCtD
Triamcinolone—Purpura—Temozolomide—malignant glioma	0.000988	0.0102	CcSEcCtD
Triamcinolone—Affect lability—Temozolomide—malignant glioma	0.000938	0.0097	CcSEcCtD
Triamcinolone—Mood swings—Temozolomide—malignant glioma	0.000902	0.00933	CcSEcCtD
Triamcinolone—Muscular weakness—Carmustine—malignant glioma	0.000869	0.00899	CcSEcCtD
Triamcinolone—Muscular weakness—Temozolomide—malignant glioma	0.00084	0.00869	CcSEcCtD
Triamcinolone—Abdominal distension—Temozolomide—malignant glioma	0.000829	0.00857	CcSEcCtD
Triamcinolone—Sweating increased—Temozolomide—malignant glioma	0.000802	0.0083	CcSEcCtD
Triamcinolone—Bronchitis—Temozolomide—malignant glioma	0.000792	0.00819	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000765	0.00791	CcSEcCtD
Triamcinolone—Weight increased—Temozolomide—malignant glioma	0.000749	0.00775	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Carmustine—malignant glioma	0.000745	0.0077	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00072	0.00744	CcSEcCtD
Triamcinolone—Haemoglobin—Carmustine—malignant glioma	0.000685	0.00709	CcSEcCtD
Triamcinolone—Haemorrhage—Carmustine—malignant glioma	0.000682	0.00705	CcSEcCtD
Triamcinolone—Haemoglobin—Temozolomide—malignant glioma	0.000662	0.00685	CcSEcCtD
Triamcinolone—Haemorrhage—Temozolomide—malignant glioma	0.000659	0.00682	CcSEcCtD
Triamcinolone—Pharyngitis—Temozolomide—malignant glioma	0.000654	0.00677	CcSEcCtD
Triamcinolone—Arrhythmia—Carmustine—malignant glioma	0.000609	0.0063	CcSEcCtD
Triamcinolone—Erythema—Carmustine—malignant glioma	0.000594	0.00614	CcSEcCtD
Triamcinolone—Back pain—Carmustine—malignant glioma	0.000574	0.00594	CcSEcCtD
Triamcinolone—Erythema—Temozolomide—malignant glioma	0.000574	0.00593	CcSEcCtD
Triamcinolone—Dysgeusia—Temozolomide—malignant glioma	0.000562	0.00581	CcSEcCtD
Triamcinolone—Back pain—Temozolomide—malignant glioma	0.000555	0.00574	CcSEcCtD
Triamcinolone—Ill-defined disorder—Temozolomide—malignant glioma	0.000532	0.00551	CcSEcCtD
Triamcinolone—Angioedema—Temozolomide—malignant glioma	0.000524	0.00542	CcSEcCtD
Triamcinolone—Malaise—Temozolomide—malignant glioma	0.000517	0.00535	CcSEcCtD
Triamcinolone—Vertigo—Temozolomide—malignant glioma	0.000515	0.00533	CcSEcCtD
Triamcinolone—Convulsion—Carmustine—malignant glioma	0.000514	0.00532	CcSEcCtD
Triamcinolone—Hypertension—Carmustine—malignant glioma	0.000513	0.0053	CcSEcCtD
Triamcinolone—Myalgia—Carmustine—malignant glioma	0.000505	0.00523	CcSEcCtD
Triamcinolone—Cough—Temozolomide—malignant glioma	0.000501	0.00518	CcSEcCtD
Triamcinolone—Convulsion—Temozolomide—malignant glioma	0.000497	0.00514	CcSEcCtD
Triamcinolone—Hypertension—Temozolomide—malignant glioma	0.000495	0.00512	CcSEcCtD
Triamcinolone—Myalgia—Temozolomide—malignant glioma	0.000488	0.00505	CcSEcCtD
Triamcinolone—Oedema—Carmustine—malignant glioma	0.000484	0.00501	CcSEcCtD
Triamcinolone—Discomfort—Temozolomide—malignant glioma	0.000483	0.00499	CcSEcCtD
Triamcinolone—Infection—Carmustine—malignant glioma	0.000481	0.00498	CcSEcCtD
Triamcinolone—Dry mouth—Temozolomide—malignant glioma	0.000478	0.00494	CcSEcCtD
Triamcinolone—Tachycardia—Carmustine—malignant glioma	0.000473	0.00489	CcSEcCtD
Triamcinolone—Anaphylactic shock—Temozolomide—malignant glioma	0.000468	0.00484	CcSEcCtD
Triamcinolone—Oedema—Temozolomide—malignant glioma	0.000468	0.00484	CcSEcCtD
Triamcinolone—Infection—Temozolomide—malignant glioma	0.000465	0.00481	CcSEcCtD
Triamcinolone—Hyperhidrosis—Temozolomide—malignant glioma	0.000453	0.00468	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000441	0.00457	CcSEcCtD
Triamcinolone—Insomnia—Carmustine—malignant glioma	0.000438	0.00453	CcSEcCtD
Triamcinolone—Paraesthesia—Carmustine—malignant glioma	0.000435	0.0045	CcSEcCtD
Triamcinolone—Dyspnoea—Carmustine—malignant glioma	0.000432	0.00447	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000427	0.00441	CcSEcCtD
Triamcinolone—Insomnia—Temozolomide—malignant glioma	0.000423	0.00438	CcSEcCtD
Triamcinolone—Paraesthesia—Temozolomide—malignant glioma	0.00042	0.00435	CcSEcCtD
Triamcinolone—Dyspnoea—Temozolomide—malignant glioma	0.000417	0.00432	CcSEcCtD
Triamcinolone—Pain—Carmustine—malignant glioma	0.000414	0.00429	CcSEcCtD
Triamcinolone—Dyspepsia—Temozolomide—malignant glioma	0.000412	0.00426	CcSEcCtD
Triamcinolone—Fatigue—Temozolomide—malignant glioma	0.000404	0.00418	CcSEcCtD
Triamcinolone—Pain—Temozolomide—malignant glioma	0.0004	0.00414	CcSEcCtD
Triamcinolone—Feeling abnormal—Carmustine—malignant glioma	0.000399	0.00413	CcSEcCtD
Triamcinolone—Feeling abnormal—Temozolomide—malignant glioma	0.000386	0.00399	CcSEcCtD
Triamcinolone—Body temperature increased—Carmustine—malignant glioma	0.000383	0.00396	CcSEcCtD
Triamcinolone—Urticaria—Temozolomide—malignant glioma	0.000372	0.00385	CcSEcCtD
Triamcinolone—Body temperature increased—Temozolomide—malignant glioma	0.00037	0.00383	CcSEcCtD
Triamcinolone—PTGS2—endothelium—malignant glioma	0.000369	0.0724	CbGeAlD
Triamcinolone—Hypersensitivity—Carmustine—malignant glioma	0.000357	0.00369	CcSEcCtD
Triamcinolone—Asthenia—Carmustine—malignant glioma	0.000348	0.0036	CcSEcCtD
Triamcinolone—Hypersensitivity—Temozolomide—malignant glioma	0.000345	0.00357	CcSEcCtD
Triamcinolone—PTGS2—blood vessel—malignant glioma	0.00034	0.0668	CbGeAlD
Triamcinolone—Asthenia—Temozolomide—malignant glioma	0.000336	0.00347	CcSEcCtD
Triamcinolone—Pruritus—Temozolomide—malignant glioma	0.000331	0.00343	CcSEcCtD
Triamcinolone—Dizziness—Carmustine—malignant glioma	0.00032	0.00331	CcSEcCtD
Triamcinolone—Dizziness—Temozolomide—malignant glioma	0.00031	0.0032	CcSEcCtD
Triamcinolone—Vomiting—Carmustine—malignant glioma	0.000308	0.00319	CcSEcCtD
Triamcinolone—Rash—Carmustine—malignant glioma	0.000305	0.00316	CcSEcCtD
Triamcinolone—Dermatitis—Carmustine—malignant glioma	0.000305	0.00316	CcSEcCtD
Triamcinolone—Headache—Carmustine—malignant glioma	0.000304	0.00314	CcSEcCtD
Triamcinolone—Vomiting—Temozolomide—malignant glioma	0.000298	0.00308	CcSEcCtD
Triamcinolone—Rash—Temozolomide—malignant glioma	0.000295	0.00305	CcSEcCtD
Triamcinolone—Dermatitis—Temozolomide—malignant glioma	0.000295	0.00305	CcSEcCtD
Triamcinolone—Headache—Temozolomide—malignant glioma	0.000293	0.00303	CcSEcCtD
Triamcinolone—Nausea—Carmustine—malignant glioma	0.000288	0.00298	CcSEcCtD
Triamcinolone—Nausea—Temozolomide—malignant glioma	0.000278	0.00288	CcSEcCtD
Triamcinolone—SERPINA6—central nervous system—malignant glioma	0.000247	0.0486	CbGeAlD
Triamcinolone—SERPINA6—cerebellum—malignant glioma	0.000242	0.0475	CbGeAlD
Triamcinolone—BCHE—brainstem—malignant glioma	0.000241	0.0474	CbGeAlD
Triamcinolone—NR3C1—embryo—malignant glioma	0.000234	0.046	CbGeAlD
Triamcinolone—NR3C1—brainstem—malignant glioma	0.000215	0.0422	CbGeAlD
Triamcinolone—BCHE—telencephalon—malignant glioma	0.000214	0.042	CbGeAlD
Triamcinolone—PTGS2—embryo—malignant glioma	0.000203	0.0398	CbGeAlD
Triamcinolone—SERPINA6—brain—malignant glioma	0.000196	0.0386	CbGeAlD
Triamcinolone—NR3C1—telencephalon—malignant glioma	0.000191	0.0374	CbGeAlD
Triamcinolone—BCHE—medulla oblongata—malignant glioma	0.000168	0.033	CbGeAlD
Triamcinolone—PTGS2—telencephalon—malignant glioma	0.000165	0.0324	CbGeAlD
Triamcinolone—BCHE—midbrain—malignant glioma	0.000154	0.0302	CbGeAlD
Triamcinolone—BCHE—spinal cord—malignant glioma	0.00015	0.0295	CbGeAlD
Triamcinolone—NR3C1—medulla oblongata—malignant glioma	0.00015	0.0294	CbGeAlD
Triamcinolone—NR3C1—midbrain—malignant glioma	0.000137	0.0269	CbGeAlD
Triamcinolone—NR3C1—spinal cord—malignant glioma	0.000134	0.0262	CbGeAlD
Triamcinolone—PTGS2—medulla oblongata—malignant glioma	0.00013	0.0254	CbGeAlD
Triamcinolone—BCHE—central nervous system—malignant glioma	0.000122	0.0239	CbGeAlD
Triamcinolone—BCHE—cerebellum—malignant glioma	0.000119	0.0234	CbGeAlD
Triamcinolone—PTGS2—midbrain—malignant glioma	0.000118	0.0233	CbGeAlD
Triamcinolone—PTGS2—spinal cord—malignant glioma	0.000116	0.0227	CbGeAlD
Triamcinolone—NR3C1—central nervous system—malignant glioma	0.000108	0.0213	CbGeAlD
Triamcinolone—NR3C1—cerebellum—malignant glioma	0.000106	0.0208	CbGeAlD
Triamcinolone—BCHE—brain—malignant glioma	9.66e-05	0.019	CbGeAlD
Triamcinolone—PTGS2—central nervous system—malignant glioma	9.38e-05	0.0184	CbGeAlD
Triamcinolone—PTGS2—cerebellum—malignant glioma	9.16e-05	0.018	CbGeAlD
Triamcinolone—NR3C1—brain—malignant glioma	8.6e-05	0.0169	CbGeAlD
Triamcinolone—CYP3A4—central nervous system—malignant glioma	8.19e-05	0.0161	CbGeAlD
Triamcinolone—PTGS2—brain—malignant glioma	7.44e-05	0.0146	CbGeAlD
Triamcinolone—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	7.38e-05	0.0027	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	7.26e-05	0.00266	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—XBP1—malignant glioma	7.16e-05	0.00263	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CG—malignant glioma	7.16e-05	0.00262	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	7.09e-05	0.0026	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—SLC6A3—malignant glioma	7.06e-05	0.00259	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	6.94e-05	0.00254	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	6.73e-05	0.00247	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	6.69e-05	0.00245	CbGpPWpGaD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	6.67e-05	0.00244	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—PPARG—malignant glioma	6.58e-05	0.00241	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	6.53e-05	0.00239	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	6.38e-05	0.00234	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	6.37e-05	0.00233	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.35e-05	0.00233	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CD—malignant glioma	6.29e-05	0.00231	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	6.19e-05	0.00227	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	6.16e-05	0.00226	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.15e-05	0.00225	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—RTEL1—malignant glioma	6.12e-05	0.00224	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	6.08e-05	0.00223	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	6.03e-05	0.00221	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	5.95e-05	0.00218	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	5.86e-05	0.00215	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	5.85e-05	0.00214	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	5.69e-05	0.00208	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	5.59e-05	0.00205	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CB—malignant glioma	5.48e-05	0.00201	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	5.48e-05	0.00201	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	5.44e-05	0.00199	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	5.44e-05	0.00199	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	5.39e-05	0.00198	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	5.36e-05	0.00197	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—SPHK1—malignant glioma	5.31e-05	0.00195	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—COX8A—malignant glioma	5.11e-05	0.00187	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	5.06e-05	0.00185	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—BRAF—malignant glioma	5e-05	0.00183	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	4.99e-05	0.00183	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	4.9e-05	0.0018	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PTEN—malignant glioma	4.74e-05	0.00174	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	4.72e-05	0.00173	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	4.65e-05	0.0017	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	4.59e-05	0.00168	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.57e-05	0.00167	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	4.45e-05	0.00163	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	4.42e-05	0.00162	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	4.38e-05	0.0016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.37e-05	0.0016	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ASMT—malignant glioma	4.34e-05	0.00159	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	4.34e-05	0.00159	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.23e-05	0.00155	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—MDM2—malignant glioma	4.19e-05	0.00154	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—RAF1—malignant glioma	4.17e-05	0.00153	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	4.16e-05	0.00153	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	4.15e-05	0.00152	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	4.11e-05	0.00151	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	4.11e-05	0.00151	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—BCAN—malignant glioma	4.08e-05	0.0015	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.08e-05	0.0015	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—STAT3—malignant glioma	4.04e-05	0.00148	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	4.03e-05	0.00148	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	3.94e-05	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	3.94e-05	0.00144	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL2—malignant glioma	3.93e-05	0.00144	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	3.92e-05	0.00144	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—BRAF—malignant glioma	3.83e-05	0.0014	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTT1—malignant glioma	3.81e-05	0.0014	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	3.8e-05	0.00139	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	3.8e-05	0.00139	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	3.76e-05	0.00138	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	3.75e-05	0.00138	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	3.73e-05	0.00137	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	3.72e-05	0.00136	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	3.62e-05	0.00133	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—FBXW7—malignant glioma	3.61e-05	0.00132	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	3.57e-05	0.00131	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	3.53e-05	0.0013	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	3.52e-05	0.00129	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—COX8A—malignant glioma	3.52e-05	0.00129	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—malignant glioma	3.49e-05	0.00128	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BCAN—malignant glioma	3.36e-05	0.00123	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	3.35e-05	0.00123	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CA—malignant glioma	3.34e-05	0.00123	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—IDH2—malignant glioma	3.29e-05	0.00121	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—MDM2—malignant glioma	3.21e-05	0.00118	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—RAF1—malignant glioma	3.2e-05	0.00117	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.2e-05	0.00117	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.14e-05	0.00115	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—DNMT3B—malignant glioma	3.13e-05	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.1e-05	0.00114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2B6—malignant glioma	3.09e-05	0.00113	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.07e-05	0.00113	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HIST1H3B—malignant glioma	3.04e-05	0.00112	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.04e-05	0.00111	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—DTX1—malignant glioma	3.03e-05	0.00111	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	3.02e-05	0.00111	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.01e-05	0.0011	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.99e-05	0.0011	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ASMT—malignant glioma	2.99e-05	0.0011	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.98e-05	0.00109	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.95e-05	0.00108	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.92e-05	0.00107	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—malignant glioma	2.86e-05	0.00105	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—IDH1—malignant glioma	2.83e-05	0.00104	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BCAN—malignant glioma	2.81e-05	0.00103	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SPHK1—malignant glioma	2.74e-05	0.001	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2C18—malignant glioma	2.68e-05	0.000983	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.68e-05	0.000981	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RTEL1—malignant glioma	2.67e-05	0.00098	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	2.64e-05	0.000969	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.61e-05	0.000956	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	2.55e-05	0.000933	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.53e-05	0.000927	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—malignant glioma	2.52e-05	0.000925	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.51e-05	0.000922	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	2.4e-05	0.000881	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HEY2—malignant glioma	2.38e-05	0.000873	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—H3F3A—malignant glioma	2.35e-05	0.000862	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IDH1—malignant glioma	2.33e-05	0.000852	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.3e-05	0.000844	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.27e-05	0.000832	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—IDH2—malignant glioma	2.27e-05	0.00083	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.22e-05	0.000815	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH3—malignant glioma	2.21e-05	0.000809	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HEY1—malignant glioma	2.2e-05	0.000808	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTT1—malignant glioma	2.17e-05	0.000795	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HIST1H3B—malignant glioma	2.14e-05	0.000785	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.14e-05	0.000783	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2B6—malignant glioma	2.13e-05	0.00078	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.09e-05	0.000766	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—F2—malignant glioma	2.08e-05	0.000762	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.04e-05	0.000749	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS1—malignant glioma	2.03e-05	0.000745	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.03e-05	0.000742	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH2—malignant glioma	1.98e-05	0.000726	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAG2—malignant glioma	1.96e-05	0.000717	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—IDH1—malignant glioma	1.95e-05	0.000714	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.95e-05	0.000713	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.93e-05	0.000708	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SPHK1—malignant glioma	1.88e-05	0.000691	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC5A5—malignant glioma	1.87e-05	0.000684	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2C18—malignant glioma	1.85e-05	0.000677	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.77e-05	0.00065	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.77e-05	0.000647	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP2—malignant glioma	1.76e-05	0.000647	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.75e-05	0.000641	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.74e-05	0.000638	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.72e-05	0.000629	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CDKN2B—malignant glioma	1.7e-05	0.000624	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—H3F3A—malignant glioma	1.65e-05	0.000606	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NCOR1—malignant glioma	1.61e-05	0.000592	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.59e-05	0.000581	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAG1—malignant glioma	1.56e-05	0.000572	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—COX8A—malignant glioma	1.54e-05	0.000563	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.53e-05	0.000561	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FBXW7—malignant glioma	1.53e-05	0.00056	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.53e-05	0.000559	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTP1—malignant glioma	1.5e-05	0.000551	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTT1—malignant glioma	1.49e-05	0.000547	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—malignant glioma	1.47e-05	0.000537	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CAT—malignant glioma	1.46e-05	0.000536	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.45e-05	0.000531	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTGS1—malignant glioma	1.4e-05	0.000513	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.39e-05	0.000511	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NCOR1—malignant glioma	1.38e-05	0.000506	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	1.37e-05	0.000502	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ASMT—malignant glioma	1.31e-05	0.000478	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BCHE—malignant glioma	1.3e-05	0.000477	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC5A5—malignant glioma	1.29e-05	0.000471	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BCAN—malignant glioma	1.23e-05	0.00045	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH1—malignant glioma	1.23e-05	0.000449	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.22e-05	0.000445	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN2B—malignant glioma	1.2e-05	0.000439	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—malignant glioma	1.16e-05	0.000424	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HES1—malignant glioma	1.14e-05	0.000419	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NCOR1—malignant glioma	1.14e-05	0.000416	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CAV1—malignant glioma	1.13e-05	0.000413	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFRA—malignant glioma	1.09e-05	0.000399	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.08e-05	0.000394	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.05e-05	0.000385	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTP1—malignant glioma	1.04e-05	0.000379	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—malignant glioma	1.03e-05	0.000376	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CAT—malignant glioma	1.01e-05	0.000369	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TERT—malignant glioma	1e-05	0.000367	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HLA-A—malignant glioma	1e-05	0.000367	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—malignant glioma	9.9e-06	0.000363	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—IDH2—malignant glioma	9.89e-06	0.000363	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFB—malignant glioma	9.77e-06	0.000358	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGFR1—malignant glioma	9.72e-06	0.000356	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HIF1A—malignant glioma	9.57e-06	0.000351	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOR1—malignant glioma	9.51e-06	0.000349	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.3e-06	0.000341	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CAV1—malignant glioma	9.26e-06	0.000339	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CD—malignant glioma	9.02e-06	0.000331	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BAD—malignant glioma	8.71e-06	0.000319	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOTCH1—malignant glioma	8.62e-06	0.000316	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—IDH1—malignant glioma	8.51e-06	0.000312	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD80—malignant glioma	8.45e-06	0.00031	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APC—malignant glioma	8.43e-06	0.000309	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGF—malignant glioma	8.34e-06	0.000306	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTPN11—malignant glioma	8.29e-06	0.000304	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SPHK1—malignant glioma	8.23e-06	0.000302	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.06e-06	0.000296	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BRAF—malignant glioma	7.93e-06	0.000291	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CB—malignant glioma	7.86e-06	0.000288	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—malignant glioma	7.79e-06	0.000286	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CAV1—malignant glioma	7.75e-06	0.000284	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT2—malignant glioma	7.72e-06	0.000283	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CD—malignant glioma	7.41e-06	0.000272	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.41e-06	0.000272	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF2—malignant glioma	7.1e-06	0.00026	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—malignant glioma	7.06e-06	0.000259	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—malignant glioma	6.82e-06	0.00025	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—malignant glioma	6.8e-06	0.000249	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MDM2—malignant glioma	6.64e-06	0.000243	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RAF1—malignant glioma	6.62e-06	0.000243	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—malignant glioma	6.6e-06	0.000242	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB2—malignant glioma	6.55e-06	0.00024	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTT1—malignant glioma	6.52e-06	0.000239	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CB—malignant glioma	6.46e-06	0.000237	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CD—malignant glioma	6.21e-06	0.000228	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS1—malignant glioma	6.11e-06	0.000224	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BCHE—malignant glioma	5.68e-06	0.000208	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.61e-06	0.000206	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—malignant glioma	5.58e-06	0.000205	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CB—malignant glioma	5.41e-06	0.000198	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—malignant glioma	4.99e-06	0.000183	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—malignant glioma	4.79e-06	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—malignant glioma	4.68e-06	0.000171	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—malignant glioma	4.64e-06	0.00017	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—malignant glioma	4.57e-06	0.000168	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGFR—malignant glioma	4.54e-06	0.000166	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTP1—malignant glioma	4.52e-06	0.000166	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CAT—malignant glioma	4.4e-06	0.000161	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—malignant glioma	4.29e-06	0.000157	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOR1—malignant glioma	4.15e-06	0.000152	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—malignant glioma	3.94e-06	0.000144	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—malignant glioma	3.92e-06	0.000144	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CAV1—malignant glioma	3.39e-06	0.000124	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—malignant glioma	3.3e-06	0.000121	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—malignant glioma	3.22e-06	0.000118	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.08e-06	0.000113	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—malignant glioma	2.98e-06	0.000109	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.71e-06	9.94e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—malignant glioma	2.7e-06	9.88e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.36e-06	8.66e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—malignant glioma	2.34e-06	8.58e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—malignant glioma	2.04e-06	7.49e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.44e-06	5.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—malignant glioma	1.18e-06	4.31e-05	CbGpPWpGaD
